Multidose container for preservative-free eye drops.
It is known that prolonged assumption of products containing preservatives such as eye drops can generate heavy side effects, especially if the drug is intended to treat a chronic condition.
With its “public statement” EMEA / 622721/2009, EMA has since long recognized the problem by suggesting producers to take appropriate measures to limit the addition of preservatives to ophthalmic specialties.
NIPRO, a Japanese manufacturer of primary containers, has developed and patented its multidose container (NP Container) for the formulation of preservative-free eye drops.
MIAT has acquired the worldwide distribution rights for their “NP Container”.
